H Influenzae Meningitis Latest Advances

Haemophilus influenzae serotype a as a cause of purulent meningitis in a six-month-old infant.

Journal: Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti

Published: June 23, 2026

Product- and schedule-specific vaccine effectiveness against invasive Haemophilus influenzae serotype b (Hib) disease, The Netherlands, 2005 to 2023.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: May 16, 2026

A Multiplex One-Tube Nested Real-Time PCR Assay for the Point-of-Care Testing of Infectious Meningitis.

Journal: Pathogens (Basel, Switzerland)

Published: April 02, 2026

Review of Cerebrospinal Fluid Isolates in Acute Bacterial Meningitis: Phenotypic Characterization and Antibiogram.

Journal: Cureus

Published: April 01, 2026

Evaluation of the Ultima Genomics UG 100 sequencer for low-cost, high-sensitivity metagenomic pathogen detection from cerebrospinal fluid.

Journal: Microbiology spectrum

Published: March 04, 2026

Epidemiology and public health response to a meningitis outbreak in Ghana's Upper West Region, 2025: a descriptive cross-sectional study.

Journal: The Pan African medical journal

Published: January 20, 2026

Persistence of Antibodies at Three, Four and Five Years of Age to Ten-valent Pneumococcal Polysaccharide Protein D-conjugate Vaccine in South African Children According to HIV Status.

Journal: The Pediatric infectious disease journal

Published: January 07, 2026

Strengthening regional surveillance: MenMap Network's year 1 findings on bacterial meningitis in Jordan, Egypt, and Iraq (2023-2024).

Journal: IJID regions

Published: January 05, 2026

Changing Clinical Spectrum of Invasive Meningococcal Disease in France (2014-2025): Impact of Age and Meningococcal Lineage on Atypical Presentations.

Journal: Microorganisms

Published: December 29, 2025

Meningococcal prophylaxis in neurological diseases treated with complement inhibitors: an expert consensus for Germany, Austria, and Switzerland.

Journal: Therapeutic advances in neurological disorders

Published: December 17, 2025

Repurposing the angiotensin II receptor blocker valsartan to inhibit penicillin-binding protein 3 and its mutants in Haemophilus influenzae: a comprehensive in silico approach.

Journal: Frontiers in bioinformatics

Published: December 11, 2025

Prevention of neuroinfectious-diseases: high impact of vaccination programs - but the potential is not maxed out yet.

Journal: Neurological research and practice

Published: December 07, 2025

H Influenzae Meningitis Latest Advances

Find the Latest Research About H Influenzae Meningitis

Haemophilus influenzae serotype a as a cause of purulent meningitis in a six-month-old infant.

Haemophilus influenzae serotype a as a cause of purulent meningitis in a six-month-old infant.

Product- and schedule-specific vaccine effectiveness against invasive Haemophilus influenzae serotype b (Hib) disease, The Netherlands, 2005 to 2023.

Product- and schedule-specific vaccine effectiveness against invasive Haemophilus influenzae serotype b (Hib) disease, The Netherlands, 2005 to 2023.

A Multiplex One-Tube Nested Real-Time PCR Assay for the Point-of-Care Testing of Infectious Meningitis.

A Multiplex One-Tube Nested Real-Time PCR Assay for the Point-of-Care Testing of Infectious Meningitis.

Review of Cerebrospinal Fluid Isolates in Acute Bacterial Meningitis: Phenotypic Characterization and Antibiogram.

Review of Cerebrospinal Fluid Isolates in Acute Bacterial Meningitis: Phenotypic Characterization and Antibiogram.

Evaluation of the Ultima Genomics UG 100 sequencer for low-cost, high-sensitivity metagenomic pathogen detection from cerebrospinal fluid.

Evaluation of the Ultima Genomics UG 100 sequencer for low-cost, high-sensitivity metagenomic pathogen detection from cerebrospinal fluid.

Epidemiology and public health response to a meningitis outbreak in Ghana's Upper West Region, 2025: a descriptive cross-sectional study.

Epidemiology and public health response to a meningitis outbreak in Ghana's Upper West Region, 2025: a descriptive cross-sectional study.

Persistence of Antibodies at Three, Four and Five Years of Age to Ten-valent Pneumococcal Polysaccharide Protein D-conjugate Vaccine in South African Children According to HIV Status.

Persistence of Antibodies at Three, Four and Five Years of Age to Ten-valent Pneumococcal Polysaccharide Protein D-conjugate Vaccine in South African Children According to HIV Status.

Strengthening regional surveillance: MenMap Network's year 1 findings on bacterial meningitis in Jordan, Egypt, and Iraq (2023-2024).

Strengthening regional surveillance: MenMap Network's year 1 findings on bacterial meningitis in Jordan, Egypt, and Iraq (2023-2024).

Changing Clinical Spectrum of Invasive Meningococcal Disease in France (2014-2025): Impact of Age and Meningococcal Lineage on Atypical Presentations.

Changing Clinical Spectrum of Invasive Meningococcal Disease in France (2014-2025): Impact of Age and Meningococcal Lineage on Atypical Presentations.

Meningococcal prophylaxis in neurological diseases treated with complement inhibitors: an expert consensus for Germany, Austria, and Switzerland.

Meningococcal prophylaxis in neurological diseases treated with complement inhibitors: an expert consensus for Germany, Austria, and Switzerland.

Repurposing the angiotensin II receptor blocker valsartan to inhibit penicillin-binding protein 3 and its mutants in Haemophilus influenzae: a comprehensive in silico approach.

Repurposing the angiotensin II receptor blocker valsartan to inhibit penicillin-binding protein 3 and its mutants in Haemophilus influenzae: a comprehensive in silico approach.

Prevention of neuroinfectious-diseases: high impact of vaccination programs - but the potential is not maxed out yet.

Prevention of neuroinfectious-diseases: high impact of vaccination programs - but the potential is not maxed out yet.